Inclisiran-based treatment strategy in <i>very high</i> cardiovascular risk patients with statin intolerance. Is the game worth the candle?

Dear EditorThe 2025 focus update for dyslipidaemia of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) highlights a more personalised strategy for LDL-cholesterol...

Authors

Francesco Sbrana (ORCID: https://orcid.org/0000-0003-4607-0373)
Beatrice Dal Pino

Institutions

Fondazione Toscana Gabriele Monasterio (IT)

Publication Details

Journal: Acta cardiologica. Supplementum
Published: 2026-07-22
DOI: https://doi.org/10.1080/00015385.2026.2704312
Primary Topic: Lipoproteins and Cardiovascular Health
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Inclisiran-based treatment strategy in very high cardiovascular risk patients with statin intolerance. Is the game worth the candle?

Francesco Sbrana, Beatrice Dal Pino

Jul 22, 2026

Acta cardiologica. Supplementum

Lipoproteins and Cardiovascular Health

article

Inclisiran-based treatment strategy in very high cardiovascular risk patients with statin intolerance. Is the game worth the candle?

Francesco Sbrana, Beatrice Dal Pino

July 22, 2026article en

Abstract

Acta cardiologica. Supplementum

Fondazione Toscana Gabriele Monasterio (IT)

Good health and well-being

Openalex Percentile: Top 6%

Lipoproteins and Cardiovascular Health

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Inclisiran-based treatment strategy in <i>very high</i> cardiovascular risk patients with statin intolerance. Is the game worth the candle? — Francesco Sbrana, Beatrice Dal Pino · Acta cardiologica. Supplementum (2026) | TGRS Research Map | TGRS